Ruihong Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ruihong Zhao has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Jianke Ma
B Department of Infectious Diseases , Cixi People's Hospital , Cixi , China
2 shared publicationsBao-Yan Xu
Department of Infectious Diseases, Southwest Hospital, Third Military Medical, University (Army Medical University), Chongqing, China
1 shared publicationBei-Ling Li
Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
1 shared publicationChen Wang
Department of Infectious Diseases, Taihe Hospital, Hubei University of Medicine, Hubei, China
1 shared publicationChun-Yan Liu
Department of Hepatology, The First Hospital of Jilin University, Jilin, China
1 shared publicationCong-Cong Zou
Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China
1 shared publication
Latest Publications
- 1 October 2020
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 18 (11) , 2564-2572.e1
Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation
- 1 October 2020
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 18 (11) , 2564-2572.e1
Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation
- 14 June 2019
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 13 (8) , 815-820
Epidemiological investigation of non-fermentative bacterial infection in cirrhotic patients
Background: This study aimed to describe the clinical characteristics of NFGNB in patients with cirrhosis as well as the risk factors for short-term mortality. Methods: A retrospective analysis was performed in patients with cirrhosis and NFGNB infections from 2011 to 2016 in the First Affiliated Hospital of Zhejiang University. Results: 144 episodes in 134 patients with liver cirrhosis and NFGNB infections were found in total. Of these, 81.2% were hospital-acquired or healthcare- associated infections, while only 18.8% of NFGNB infections originated from the community. A. baumannii were the most frequently isolated bacteria (39 episodes), followed by S. maltophilia and P. aeruginosa (38 and 31 episodes, respectively). MDR- and non-MDR-NFGNB comprised 62.5% (90/144) and 37.5% (54/144) of infections respectively. The Kaplan-Meier survival curve showed no significant difference between MDR and non-MDR NFGNB patients (74.1% vs 75.5%, P=0.811). Neither MDR or the subgroup of common NFGNB (P. aeruginosa, A. baumannii, S. maltophilia) was associated with the 28-day mortality (all P values >0.05). Low albumin levels and high Tbil levels were both independent risk factors for 28-day mortality (HR=0.930, 95%CI (0.869, 0.995), P=0.035; HR=1.003, 95%CI (1.002, 1.005), P<0.001, respectively). Conclusions: Diabetes increased 28-day mortality significantly, however, MDR status, site of infection and bacteria type did not.
- 14 June 2019
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 13 (8) , 815-820
Epidemiological investigation of non-fermentative bacterial infection in cirrhotic patients
Background: This study aimed to describe the clinical characteristics of NFGNB in patients with cirrhosis as well as the risk factors for short-term mortality. Methods: A retrospective analysis was performed in patients with cirrhosis and NFGNB infections from 2011 to 2016 in the First Affiliated Hospital of Zhejiang University. Results: 144 episodes in 134 patients with liver cirrhosis and NFGNB infections were found in total. Of these, 81.2% were hospital-acquired or healthcare- associated infections, while only 18.8% of NFGNB infections originated from the community. A. baumannii were the most frequently isolated bacteria (39 episodes), followed by S. maltophilia and P. aeruginosa (38 and 31 episodes, respectively). MDR- and non-MDR-NFGNB comprised 62.5% (90/144) and 37.5% (54/144) of infections respectively. The Kaplan-Meier survival curve showed no significant difference between MDR and non-MDR NFGNB patients (74.1% vs 75.5%, P=0.811). Neither MDR or the subgroup of common NFGNB (P. aeruginosa, A. baumannii, S. maltophilia) was associated with the 28-day mortality (all P values >0.05). Low albumin levels and high Tbil levels were both independent risk factors for 28-day mortality (HR=0.930, 95%CI (0.869, 0.995), P=0.035; HR=1.003, 95%CI (1.002, 1.005), P<0.001, respectively). Conclusions: Diabetes increased 28-day mortality significantly, however, MDR status, site of infection and bacteria type did not.
- 18 January 2019
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 13 (3) , 263-269
Upper gastrointestinal hemorrhage in acute-on-chronic liver failure: prevalence, characteristics, and impact on prognosis
Background: Upper gastrointestinal hemorrhage (UGH) is a life-threatening complication in patients with cirrhosis; however, data regarding the role of UGH in acute-on-chronic liver failure (ACLF) are limited. Methods: A prospective, observational cohort study was performed from February 2014 to Mach 2015. Results: UGH was identified in 170 of 492 cirrhotic patients with acute decompensation (AD) at the time of admission. Logistic regression analysis showed that fecal occult blood test positivity was an independent risk factor for UGH in patients with or without ACLF [OR(95%CI): 8.31(4.89–14.10), p<0.001; and 6.29 (1.48–26.76), p=0.031]. Other independent risk factors were a history of gastrointestinal bleeding [OR(95% CI): 13.43 (7.17–25.15), p<0.001], older age [OR(95% CI): 0.98(0.96–0.99), p=0.003], greater INR level [OR(95% CI): 0.48(0.28–0.81), p=0.007] in patients without ACLF. Multivariate Cox proportional hazard model analysis indicated that UGH did not increase mortality at different times in cirrhotic patients with acute decompensation. Conclusions: UGH is a frequent complication in cirrhotic patients with AD, even those with ACLF. Positive fecal occult blood tests and previous GI bleeding were shown to be associated with the risk of UGH. UGH did not significantly increase the risk of mortality in cirrhotic patients with AD or ACLF.
- 18 January 2019
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 13 (3) , 263-269
Upper gastrointestinal hemorrhage in acute-on-chronic liver failure: prevalence, characteristics, and impact on prognosis
Background: Upper gastrointestinal hemorrhage (UGH) is a life-threatening complication in patients with cirrhosis; however, data regarding the role of UGH in acute-on-chronic liver failure (ACLF) are limited. Methods: A prospective, observational cohort study was performed from February 2014 to Mach 2015. Results: UGH was identified in 170 of 492 cirrhotic patients with acute decompensation (AD) at the time of admission. Logistic regression analysis showed that fecal occult blood test positivity was an independent risk factor for UGH in patients with or without ACLF [OR(95%CI): 8.31(4.89–14.10), p<0.001; and 6.29 (1.48–26.76), p=0.031]. Other independent risk factors were a history of gastrointestinal bleeding [OR(95% CI): 13.43 (7.17–25.15), p<0.001], older age [OR(95% CI): 0.98(0.96–0.99), p=0.003], greater INR level [OR(95% CI): 0.48(0.28–0.81), p=0.007] in patients without ACLF. Multivariate Cox proportional hazard model analysis indicated that UGH did not increase mortality at different times in cirrhotic patients with acute decompensation. Conclusions: UGH is a frequent complication in cirrhotic patients with AD, even those with ACLF. Positive fecal occult blood tests and previous GI bleeding were shown to be associated with the risk of UGH. UGH did not significantly increase the risk of mortality in cirrhotic patients with AD or ACLF.
- 5 September 2018
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 12 (11) , 1167-1174
Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study
The purpose of this study is to describe the epidemiological features of bacterial infections caused by multidrug-resistant (MDR) bacteria in cirrhotic patients and their impact on mortality. A retrospective study of cirrhotic patients with culture-confirmed bacterial infections was performed between 2011 and 2017. A total of 635 episodes in 563 patients with cirrhosis were included. Bacterial infections caused by MDR isolates accounted for 44.1% (280/635) of the episodes, nearly half of which were hospital acquired (48.4%). The most common MDR isolation site was the respiratory tract (36.4%, 102 episodes), followed by the abdominal cavity (35.4%, 99 episodes). Of the MDR isolates, carbapenem-resistant Enterobacteriaceae (CRE) (91 episodes) were the most common. Patients infected with MDR bacteria had significantly higher mortality than those not infected (25.1% vs 17.4%, p = 0.025). However, this increased mortality could be largely attributed to methicillin-resistant Staphylococcus aureus (MRSA). After adjustment for age, sex, and the model for end-stage liver disease (MELD) score, only MRSA infection was an independent risk factor for 28-day mortality in the multivariable Cox proportional hazard regression model analysis (HR, 2.964, 95% CI (1.175-7.478), p = 0.021). MDR bacterial infections, especially CRE, have become frequent in patients with cirrhosis in recent years, with MRSA infections significantly increasing short-term mortality.
- 5 September 2018
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 12 (11) , 1167-1174
Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study
The purpose of this study is to describe the epidemiological features of bacterial infections caused by multidrug-resistant (MDR) bacteria in cirrhotic patients and their impact on mortality. A retrospective study of cirrhotic patients with culture-confirmed bacterial infections was performed between 2011 and 2017. A total of 635 episodes in 563 patients with cirrhosis were included. Bacterial infections caused by MDR isolates accounted for 44.1% (280/635) of the episodes, nearly half of which were hospital acquired (48.4%). The most common MDR isolation site was the respiratory tract (36.4%, 102 episodes), followed by the abdominal cavity (35.4%, 99 episodes). Of the MDR isolates, carbapenem-resistant Enterobacteriaceae (CRE) (91 episodes) were the most common. Patients infected with MDR bacteria had significantly higher mortality than those not infected (25.1% vs 17.4%, p = 0.025). However, this increased mortality could be largely attributed to methicillin-resistant Staphylococcus aureus (MRSA). After adjustment for age, sex, and the model for end-stage liver disease (MELD) score, only MRSA infection was an independent risk factor for 28-day mortality in the multivariable Cox proportional hazard regression model analysis (HR, 2.964, 95% CI (1.175-7.478), p = 0.021). MDR bacterial infections, especially CRE, have become frequent in patients with cirrhosis in recent years, with MRSA infections significantly increasing short-term mortality.